Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Document › Details

908 Devices, Inc.. (1/9/19). "Press Release: 908 Devices’ High-Pressure Mass Spectrometry (HPMS) Technology to Power Next-Generation Advanced Chemical Threat Detector for U.S. Department of Defense". Boston, MA.

	Region	United States (USA)
	Organisation	908 Devices Inc. (Nasdaq: MASS)
	Group	908 Devices (Group)
	Organisation 2	Department of Defense (DOD) (US)
	Group	United States (govt)
	Product	high-pressure mass spectrometry (HPMS™ technology)
	Product 2	chemical analyzer
	Person	Knopp, Kevin J. (908 Devices 201303 CEO + Co-founder before Thermo Fisher + Ahura Scientific)

The company and joint partner Smiths Detection selected to develop Aerosol and Vapor Chemical Agent Detector (AVCAD)

908 Devices Inc., a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, today announced they will provide their High-Pressure Mass Spectrometry™ (HPMS) technology platform to the next phase of the U.S. Department of Defense's (DOD) new Aerosol and Vapor Chemical Agent Detector (AVCAD) program. The company and partner Smiths Detection, a worldwide leader and proven integrator for detection systems, were selected by the DOD's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)'s Joint Project Manager, Nuclear Biological Chemical Contamination Avoidance to be one of only two suppliers to move into the engineering and manufacturing phase for the AVCAD.

908 Devices' HPMS technology is the core of the company's commercially available devices, including the MX908™ trace chemical detection device. During the development phase of the AVCAD project, the DOD extensively tested the selectivity, sensitivity and capability of HPMS.

"Being selected for the next phase of this program is tremendous validation of our foundational technology platform and represents a major milestone in our pursuit to deliver on a new standard of chemical detection," said Dr. Kevin J. Knopp, President and CEO of 908 Devices. "We look forward to working in partnership with Smiths Detection on the AVCAD in this next phase and are truly honored to have a role in protecting our U.S. military."

About 908 Devices

908 Devices is setting off a revolution in how chemical analysis gets done. We offer point-of-need chemical and biomolecular analysis devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. These purpose-built and user-centric devices serve the life science, field forensics and other applied markets. 908 Devices is headquartered in the heart of Boston where we research, design and manufacture innovative products based on high-pressure mass spectrometry™ (HPMS) and microfluidic separation technology. For more information, visit 908devices.com.

Record changed: 2023-06-05